Adastra Labs Holdings Ltd. (D2E0) Stock Price & Analysis

2 Followers

D2E0 Stock Chart & Stats

€0.08€0.00(0.00%)

At close: Nov 11 5:30 PM GMT+1

Day’s Range: EUR 0.08 - EUR 0.08
52-Week Range: EUR 0.07 - EUR 0.15
Previous Close: EUR 0.08
Volume: N/A
Average Volume (3M): 0
Market Cap: EUR 707.95K
Enterprise Value: EUR 4.56M
Total Cash (Recent Filing): EUR 786.60K
Total Debt (Recent Filing): EUR 3.57M
Price to Earnings (P/E): ―
Beta: -2.28
Next Earnings: Nov 26, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Specialized B2B Extraction And Formulation

Adastra Labs operates a focused, specialty business supplying refined cannabinoid ingredients to manufacturers. That B2B ingredient model is durable: it relies on production know-how and contract relationships rather than retail foot traffic, supporting steady demand from downstream brands and potential for long-term supply agreements.

Diversified End-market Exposure (consumer & Medical)

Serving both consumer and medical product manufacturers gives the company structurally broader demand drivers. Exposure across therapeutic and consumer segments reduces reliance on any single product cycle and can smooth revenue volatility over time as different end markets respond differently to regulation and consumer trends.

Moderate Gross Profit Margin On Core Processing

A mid-30% gross margin indicates the core extraction and formulation process has reasonable unit economics. Even though operating profitability is currently negative, this gross margin suggests there is a structural ability to generate production-level profit that could flow to the bottom line with tighter operating expense control or scale improvements.

Bears Say

Declining Revenue And Large Losses

Revenues are declining materially while net margins are deeply negative, indicating the business is shrinking while losing cash on sales. Sustained top-line contraction combined with heavy losses undermines scale economics, limits reinvestment capacity, and makes achieving a durable turnaround more difficult without clear demand or margin recovery.

Negative Equity And Solvency Risk

Negative shareholder equity and an extreme debt-to-equity ratio signal structural balance-sheet weakness and potential solvency stress. This reduces financial flexibility, increases refinancing risk, and can constrain investment or growth initiatives, forcing management to prioritize capital restructuring over strategic opportunities.

Persistent Negative Operating And Free Cash Flow

Ongoing negative operating and free cash flows show the company is burning cash from core operations. Persistent cash deficits limit the ability to fund working capital, R&D, or capex internally and increase dependence on external financing, which may be costly or unavailable given the weak balance sheet and operating losses.

Adastra Labs Holdings Ltd. News

Adastra Sells Extraction Assets in Leaseback Deal as Director Resigns

Adastra Labs Holdings Ltd. ( ($TSE:XTRX) ) just unveiled an announcement. Adastra Holdings Ltd. announced that its wholly owned subsidiary, Adastra Labs Inc., has agreed to sell certain cryoethanol and

8M agoD2E0 XTRX

Adastra Holdings Completes Subsidiary Sale to Streamline Operations

The latest update is out from Adastra Labs Holdings Ltd. ( ($TSE:XTRX) ). Adastra Holdings Ltd. has completed the sale of its subsidiaries, Adastra Labs Holdings (2019) Ltd., 1178562 B.C.

1y agoD2E0 XTRX

Adastra Holdings to Sell Subsidiaries in Strategic Move

Adastra Labs Holdings Ltd. ( ($TSE:XTRX) ) has shared an update. Adastra Holdings Ltd. has announced agreements to sell its subsidiaries, Adastra Labs Holdings (2019) Ltd., 1178562 B.C. Ltd., and

1y agoD2E0 XTRX

Adastra Holdings Appoints New Director to Board

Adastra Labs Holdings Ltd. ( ($TSE:XTRX) ) just unveiled an update. Adastra Holdings Ltd. has announced the appointment of Mark Qvist to its board of directors, effective February 28, 2025.

1y agoD2E0 XTRX

Adastra Holdings Confirms Management Changes Amidst Strategic Growth

Adastra Labs Holdings Ltd. ( ($TSE:XTRX) ) just unveiled an update. Adastra Holdings Ltd. has confirmed its current management structure following a review by the British Columbia Securities Commission. Lachlan

1y agoD2E0 XTRX

Adastra Holdings Schedules Virtual Annual General Meeting

Adastra Labs Holdings Ltd. (TSE:XTRX) has released an update. Adastra Holdings Ltd., a prominent player in cannabis processing, has announced its virtual 2024 Annual General Meeting set for December 13,

1y agoD2E0 XTRX

Adastra Holdings Announces Major Share Consolidation

Adastra Labs Holdings Ltd. (TSE:XTRX) has released an update. Adastra Holdings Ltd., a leading cannabis processor, is set to undergo a significant reduction in its number of shares through a

2y agoD2E XTRX

Adastra Holdings Announces Executive Resignation

Adastra Labs Holdings Ltd. (TSE:XTRX) has released an update. Adastra Holdings Ltd., a prominent Canadian cannabis processor, has announced the resignation of Lachlan McLeod from his interim roles as CEO,

2y agoD2E XTRX

Adastra Labs to End SEC Reporting Obligations

Adastra Labs Holdings Ltd. (TSE:XTRX) has released an update. Adastra Holdings Ltd., a prominent Canadian cannabis processor, has announced plans to cease its reporting obligations to the U.S. Securities and

2y agoD2E XTRX

Adastra Holdings Triumphs with Record Revenues

Adastra Labs Holdings Ltd. (TSE:XTRX) has released an update. Adastra Holdings Ltd. celebrates a remarkable year with a record-breaking $37.7 million in gross revenue for FY2023, a 108% increase from

2y agoD2E XTRX

D2E0 FAQ

What was Adastra Labs Holdings Ltd.’s price range in the past 12 months?

Adastra Labs Holdings Ltd. lowest stock price was €0.07 and its highest was €0.15 in the past 12 months.

What is Adastra Labs Holdings Ltd.’s market cap?

Adastra Labs Holdings Ltd.’s market cap is €707.95K.

When is Adastra Labs Holdings Ltd.’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Adastra Labs Holdings Ltd.’s earnings last quarter?

Adastra Labs Holdings Ltd. released its earnings results on Dec 01, 2025. The company reported -€0.072 earnings per share for the quarter.

Is Adastra Labs Holdings Ltd. overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Adastra Labs Holdings Ltd. pay dividends?

Adastra Labs Holdings Ltd. does not currently pay dividends.

What is Adastra Labs Holdings Ltd.’s EPS estimate?

Adastra Labs Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Adastra Labs Holdings Ltd. have?

Adastra Labs Holdings Ltd. has 5,597,050 shares outstanding.

What happened to Adastra Labs Holdings Ltd.’s price movement after its last earnings report?

Adastra Labs Holdings Ltd. reported an EPS of -€0.072 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Adastra Labs Holdings Ltd.?

Currently, no hedge funds are holding shares in DE:D2E0

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description